Alex Plus Versus Xience Drug-Eluting Stents for Percutaneous Coronary Intervention in Routine Clinical Practice: A Propensity Score-Matched Analysis.
J Invasive Cardiol. 2022 Apr;34(4):E319-E325.
J Invasive Cardiol. 2022.
PMID: 35366226
Free article.
Despite such favorable features, limited data are available to estimate the risk-benefit profile of Alex Plus. We aimed at comparing the effectiveness of Alex Plus in real-world practice. ...Even after propensity-score matching, Alex Plus …
Despite such favorable features, limited data are available to estimate the risk-benefit profile of Alex Plus. We aimed at com …